12/23/2025 | Press release | Distributed by Public on 12/23/2025 13:30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES
Investment Company Act file number 811-06444
Legg Mason Partners Investment Trust
(Exact name of registrant as specified in charter)
One Madison Avenue, 17th Floor, New York, NY 10010
(Address of principal executive offices) (Zip code)
Marc A. De Oliveira
Franklin Templeton
100 First Stamford Place
Stamford, CT 06902
(Name and address of agent for service)
Registrant's telephone number, including area code: 877-6LM-FUND/656-3863
Date of fiscal year end: October 31
Date of reporting period: October 31, 2025
| ITEM 1. | REPORT TO STOCKHOLDERS |
(a) The Report to Shareholders is filed herewith
|
ClearBridge Mid Cap Fund
|
|
|
Class 1[SMCPX]
|
Annual Shareholder Report | October 31, 2025
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class 1
|
$88
|
0.84%
|
| * | Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
|
Top contributors to performance:
|
|
|
↑
|
AppLovin, in the IT sector, engages in building a software-based platform for advertisers to enhance the marketing and monetization of their content, particularly in mobile apps. AppLovin shares rose on several successive quarter earnings, with sustained growth from the company's core gaming business and increased optimism around catalyst driven growth in its emerging e-commerce business.
|
|
↑
|
Resideo Technologies, in the industrials sector, is a global leader in smart-home systems and controls including security, HVAC, water, and safety products. The stock rose as opportunities for margin improvement and compounding of revenue growth were augmented by potential separation of two business units to lock sum of the parts value.
|
|
↑
|
Rubrik, in the IT sector, provides data security solutions for individuals and businesses. The company continued to benefit from customers' increasing prioritization and spending on IT security. Its cloud-based offerings have resonated with its Fortune 500 customer base, positioning it to take shares from legacy data backup providers, while new artificial intelligence (AI) data security products could offer an additional revenue source to Rubrik's business.
|
|
Top detractors from performance:
|
|
|
↓
|
Alexandria Real Estate Equities, in the real estate sector, is a real estate investment trust (REIT) focused on life science, technology and agricultural technology campuses. The company's share price fell in response to a dip in occupancy levels and delayed asset sales, as well as concern about demand for lab space by biotech and pharmaceutical companies.
|
|
↓
|
Ultragenyx Pharmaceutical, in the health care sector, is a biotechnology company developing therapeutics to treat rare diseases. The stock came under pressure due to a regulatory rejection for its gene therapy candidate UX111 for Sanfilippo syndrome, a delay of final data for the clinical trial of an important drug development candidate, setrusumab, and questions about the company's ability to fund ongoing drug development spending in excess of commercial revenue.
|
|
↓
|
Avantor, in the health care sector, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company continued to improve its operating margins, but end market trends have been difficult.
|
| ClearBridge Mid Cap Fund | PAGE 1 | 7709-ATSR-1225 |
|
1 Year
|
5 Year
|
10 Year
|
|
|
Class 1
|
8.34
|
8.50
|
7.54
|
|
Russell 3000 Index
|
20.81
|
16.74
|
14.08
|
|
Russell Midcap Index
|
10.79
|
12.33
|
10.63
|
|
Total Net Assets
|
$1,629,290,655
|
|
Total Number of Portfolio Holdings
|
64
|
|
Total Management Fee Paid
|
$12,203,390
|
|
Portfolio Turnover Rate
|
29%
|
| * | Does not include derivatives, except purchased options, if any. |
| ClearBridge Mid Cap Fund | PAGE 2 | 7709-ATSR-1225 |
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
| ClearBridge Mid Cap Fund | PAGE 3 | 7709-ATSR-1225 |
|
ClearBridge Mid Cap Fund
|
|
|
Class A[SBMAX]
|
Annual Shareholder Report | October 31, 2025
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class A
|
$119
|
1.14%
|
| * | Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
|
Top contributors to performance:
|
|
|
↑
|
AppLovin, in the IT sector, engages in building a software-based platform for advertisers to enhance the marketing and monetization of their content, particularly in mobile apps. AppLovin shares rose on several successive quarter earnings, with sustained growth from the company's core gaming business and increased optimism around catalyst driven growth in its emerging e-commerce business.
|
|
↑
|
Resideo Technologies, in the industrials sector, is a global leader in smart-home systems and controls including security, HVAC, water, and safety products. The stock rose as opportunities for margin improvement and compounding of revenue growth were augmented by potential separation of two business units to lock sum of the parts value.
|
|
↑
|
Rubrik, in the IT sector, provides data security solutions for individuals and businesses. The company continued to benefit from customers' increasing prioritization and spending on IT security. Its cloud-based offerings have resonated with its Fortune 500 customer base, positioning it to take shares from legacy data backup providers, while new artificial intelligence (AI) data security products could offer an additional revenue source to Rubrik's business.
|
|
Top detractors from performance:
|
|
|
↓
|
Alexandria Real Estate Equities, in the real estate sector, is a real estate investment trust (REIT) focused on life science, technology and agricultural technology campuses. The company's share price fell in response to a dip in occupancy levels and delayed asset sales, as well as concern about demand for lab space by biotech and pharmaceutical companies.
|
|
↓
|
Ultragenyx Pharmaceutical, in the health care sector, is a biotechnology company developing therapeutics to treat rare diseases. The stock came under pressure due to a regulatory rejection for its gene therapy candidate UX111 for Sanfilippo syndrome, a delay of final data for the clinical trial of an important drug development candidate, setrusumab, and questions about the company's ability to fund ongoing drug development spending in excess of commercial revenue.
|
|
↓
|
Avantor, in the health care sector, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company continued to improve its operating margins, but end market trends have been difficult.
|
| ClearBridge Mid Cap Fund | PAGE 1 | 7641-ATSR-1225 |
|
1 Year
|
5 Year
|
10 Year
|
|
|
Class A
|
8.05
|
8.16
|
7.20
|
|
Class A (with sales charge)
|
2.09
|
6.89
|
6.56
|
|
Russell 3000 Index
|
20.81
|
16.74
|
14.08
|
|
Russell Midcap Index
|
10.79
|
12.33
|
10.63
|
|
Total Net Assets
|
$1,629,290,655
|
|
Total Number of Portfolio Holdings
|
64
|
|
Total Management Fee Paid
|
$12,203,390
|
|
Portfolio Turnover Rate
|
29%
|
| ClearBridge Mid Cap Fund | PAGE 2 | 7641-ATSR-1225 |
| * | Does not include derivatives, except purchased options, if any. |
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
| ClearBridge Mid Cap Fund | PAGE 3 | 7641-ATSR-1225 |
|
ClearBridge Mid Cap Fund
|
|
|
Class C[SBMLX]
|
Annual Shareholder Report | October 31, 2025
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class C
|
$195
|
1.88%
|
| * | Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
|
Top contributors to performance:
|
|
|
↑
|
AppLovin, in the IT sector, engages in building a software-based platform for advertisers to enhance the marketing and monetization of their content, particularly in mobile apps. AppLovin shares rose on several successive quarter earnings, with sustained growth from the company's core gaming business and increased optimism around catalyst driven growth in its emerging e-commerce business.
|
|
↑
|
Resideo Technologies, in the industrials sector, is a global leader in smart-home systems and controls including security, HVAC, water, and safety products. The stock rose as opportunities for margin improvement and compounding of revenue growth were augmented by potential separation of two business units to lock sum of the parts value.
|
|
↑
|
Rubrik, in the IT sector, provides data security solutions for individuals and businesses. The company continued to benefit from customers' increasing prioritization and spending on IT security. Its cloud-based offerings have resonated with its Fortune 500 customer base, positioning it to take shares from legacy data backup providers, while new artificial intelligence (AI) data security products could offer an additional revenue source to Rubrik's business.
|
|
Top detractors from performance:
|
|
|
↓
|
Alexandria Real Estate Equities, in the real estate sector, is a real estate investment trust (REIT) focused on life science, technology and agricultural technology campuses. The company's share price fell in response to a dip in occupancy levels and delayed asset sales, as well as concern about demand for lab space by biotech and pharmaceutical companies.
|
|
↓
|
Ultragenyx Pharmaceutical, in the health care sector, is a biotechnology company developing therapeutics to treat rare diseases. The stock came under pressure due to a regulatory rejection for its gene therapy candidate UX111 for Sanfilippo syndrome, a delay of final data for the clinical trial of an important drug development candidate, setrusumab, and questions about the company's ability to fund ongoing drug development spending in excess of commercial revenue.
|
|
↓
|
Avantor, in the health care sector, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company continued to improve its operating margins, but end market trends have been difficult.
|
| ClearBridge Mid Cap Fund | PAGE 1 | 7643-ATSR-1225 |
|
1 Year
|
5 Year
|
10 Year
|
|
|
Class C
|
7.22
|
7.38
|
6.44
|
|
Class C (with sales charge)
|
6.27
|
7.38
|
6.44
|
|
Russell 3000 Index
|
20.81
|
16.74
|
14.08
|
|
Russell Midcap Index
|
10.79
|
12.33
|
10.63
|
|
Total Net Assets
|
$1,629,290,655
|
|
Total Number of Portfolio Holdings
|
64
|
|
Total Management Fee Paid
|
$12,203,390
|
|
Portfolio Turnover Rate
|
29%
|
| * | Does not include derivatives, except purchased options, if any. |
| ClearBridge Mid Cap Fund | PAGE 2 | 7643-ATSR-1225 |
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
| ClearBridge Mid Cap Fund | PAGE 3 | 7643-ATSR-1225 |
|
ClearBridge Mid Cap Fund
|
|
|
Class R[LMREX]
|
Annual Shareholder Report | October 31, 2025
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class R
|
$151
|
1.45%
|
| * | Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
|
Top contributors to performance:
|
|
|
↑
|
AppLovin, in the IT sector, engages in building a software-based platform for advertisers to enhance the marketing and monetization of their content, particularly in mobile apps. AppLovin shares rose on several successive quarter earnings, with sustained growth from the company's core gaming business and increased optimism around catalyst driven growth in its emerging e-commerce business.
|
|
↑
|
Resideo Technologies, in the industrials sector, is a global leader in smart-home systems and controls including security, HVAC, water, and safety products. The stock rose as opportunities for margin improvement and compounding of revenue growth were augmented by potential separation of two business units to lock sum of the parts value.
|
|
↑
|
Rubrik, in the IT sector, provides data security solutions for individuals and businesses. The company continued to benefit from customers' increasing prioritization and spending on IT security. Its cloud-based offerings have resonated with its Fortune 500 customer base, positioning it to take shares from legacy data backup providers, while new artificial intelligence (AI) data security products could offer an additional revenue source to Rubrik's business.
|
|
Top detractors from performance:
|
|
|
↓
|
Alexandria Real Estate Equities, in the real estate sector, is a real estate investment trust (REIT) focused on life science, technology and agricultural technology campuses. The company's share price fell in response to a dip in occupancy levels and delayed asset sales, as well as concern about demand for lab space by biotech and pharmaceutical companies.
|
|
↓
|
Ultragenyx Pharmaceutical, in the health care sector, is a biotechnology company developing therapeutics to treat rare diseases. The stock came under pressure due to a regulatory rejection for its gene therapy candidate UX111 for Sanfilippo syndrome, a delay of final data for the clinical trial of an important drug development candidate, setrusumab, and questions about the company's ability to fund ongoing drug development spending in excess of commercial revenue.
|
|
↓
|
Avantor, in the health care sector, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company continued to improve its operating margins, but end market trends have been difficult.
|
| ClearBridge Mid Cap Fund | PAGE 1 | 7047-ATSR-1225 |
|
1 Year
|
5 Year
|
10 Year
|
|
|
Class R
|
7.69
|
7.83
|
6.89
|
|
Russell 3000 Index
|
20.81
|
16.74
|
14.08
|
|
Russell Midcap Index
|
10.79
|
12.33
|
10.63
|
|
Total Net Assets
|
$1,629,290,655
|
|
Total Number of Portfolio Holdings
|
64
|
|
Total Management Fee Paid
|
$12,203,390
|
|
Portfolio Turnover Rate
|
29%
|
| * | Does not include derivatives, except purchased options, if any. |
| ClearBridge Mid Cap Fund | PAGE 2 | 7047-ATSR-1225 |
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
| ClearBridge Mid Cap Fund | PAGE 3 | 7047-ATSR-1225 |
|
ClearBridge Mid Cap Fund
|
|
|
Class I[SMBYX]
|
Annual Shareholder Report | October 31, 2025
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class I
|
$86
|
0.83%
|
| * | Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
|
Top contributors to performance:
|
|
|
↑
|
AppLovin, in the IT sector, engages in building a software-based platform for advertisers to enhance the marketing and monetization of their content, particularly in mobile apps. AppLovin shares rose on several successive quarter earnings, with sustained growth from the company's core gaming business and increased optimism around catalyst driven growth in its emerging e-commerce business.
|
|
↑
|
Resideo Technologies, in the industrials sector, is a global leader in smart-home systems and controls including security, HVAC, water, and safety products. The stock rose as opportunities for margin improvement and compounding of revenue growth were augmented by potential separation of two business units to lock sum of the parts value.
|
|
↑
|
Rubrik, in the IT sector, provides data security solutions for individuals and businesses. The company continued to benefit from customers' increasing prioritization and spending on IT security. Its cloud-based offerings have resonated with its Fortune 500 customer base, positioning it to take shares from legacy data backup providers, while new artificial intelligence (AI) data security products could offer an additional revenue source to Rubrik's business.
|
|
Top detractors from performance:
|
|
|
↓
|
Alexandria Real Estate Equities, in the real estate sector, is a real estate investment trust (REIT) focused on life science, technology and agricultural technology campuses. The company's share price fell in response to a dip in occupancy levels and delayed asset sales, as well as concern about demand for lab space by biotech and pharmaceutical companies.
|
|
↓
|
Ultragenyx Pharmaceutical, in the health care sector, is a biotechnology company developing therapeutics to treat rare diseases. The stock came under pressure due to a regulatory rejection for its gene therapy candidate UX111 for Sanfilippo syndrome, a delay of final data for the clinical trial of an important drug development candidate, setrusumab, and questions about the company's ability to fund ongoing drug development spending in excess of commercial revenue.
|
|
↓
|
Avantor, in the health care sector, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company continued to improve its operating margins, but end market trends have been difficult.
|
| ClearBridge Mid Cap Fund | PAGE 1 | 7644-ATSR-1225 |
|
1 Year
|
5 Year
|
10 Year
|
|
|
Class I
|
8.38
|
8.48
|
7.54
|
|
Russell 3000 Index
|
20.81
|
16.74
|
14.08
|
|
Russell Midcap Index
|
10.79
|
12.33
|
10.63
|
|
Total Net Assets
|
$1,629,290,655
|
|
Total Number of Portfolio Holdings
|
64
|
|
Total Management Fee Paid
|
$12,203,390
|
|
Portfolio Turnover Rate
|
29%
|
| * | Does not include derivatives, except purchased options, if any. |
| ClearBridge Mid Cap Fund | PAGE 2 | 7644-ATSR-1225 |
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
| ClearBridge Mid Cap Fund | PAGE 3 | 7644-ATSR-1225 |
|
ClearBridge Mid Cap Fund
|
|
|
Class IS[LSIRX]
|
Annual Shareholder Report | October 31, 2025
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class IS
|
$78
|
0.75%
|
| * | Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
|
Top contributors to performance:
|
|
|
↑
|
AppLovin, in the IT sector, engages in building a software-based platform for advertisers to enhance the marketing and monetization of their content, particularly in mobile apps. AppLovin shares rose on several successive quarter earnings, with sustained growth from the company's core gaming business and increased optimism around catalyst driven growth in its emerging e-commerce business.
|
|
↑
|
Resideo Technologies, in the industrials sector, is a global leader in smart-home systems and controls including security, HVAC, water, and safety products. The stock rose as opportunities for margin improvement and compounding of revenue growth were augmented by potential separation of two business units to lock sum of the parts value.
|
|
↑
|
Rubrik, in the IT sector, provides data security solutions for individuals and businesses. The company continued to benefit from customers' increasing prioritization and spending on IT security. Its cloud-based offerings have resonated with its Fortune 500 customer base, positioning it to take shares from legacy data backup providers, while new artificial intelligence (AI) data security products could offer an additional revenue source to Rubrik's business.
|
|
Top detractors from performance:
|
|
|
↓
|
Alexandria Real Estate Equities, in the real estate sector, is a real estate investment trust (REIT) focused on life science, technology and agricultural technology campuses. The company's share price fell in response to a dip in occupancy levels and delayed asset sales, as well as concern about demand for lab space by biotech and pharmaceutical companies.
|
|
↓
|
Ultragenyx Pharmaceutical, in the health care sector, is a biotechnology company developing therapeutics to treat rare diseases. The stock came under pressure due to a regulatory rejection for its gene therapy candidate UX111 for Sanfilippo syndrome, a delay of final data for the clinical trial of an important drug development candidate, setrusumab, and questions about the company's ability to fund ongoing drug development spending in excess of commercial revenue.
|
|
↓
|
Avantor, in the health care sector, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company continued to improve its operating margins, but end market trends have been difficult.
|
| ClearBridge Mid Cap Fund | PAGE 1 | 7963-ATSR-1225 |
|
1 Year
|
5 Year
|
10 Year
|
|
|
Class IS
|
8.46
|
8.58
|
7.64
|
|
Russell 3000 Index
|
20.81
|
16.74
|
14.08
|
|
Russell Midcap Index
|
10.79
|
12.33
|
10.63
|
|
Total Net Assets
|
$1,629,290,655
|
|
Total Number of Portfolio Holdings
|
64
|
|
Total Management Fee Paid
|
$12,203,390
|
|
Portfolio Turnover Rate
|
29%
|
| * | Does not include derivatives, except purchased options, if any. |
| ClearBridge Mid Cap Fund | PAGE 2 | 7963-ATSR-1225 |
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
| ClearBridge Mid Cap Fund | PAGE 3 | 7963-ATSR-1225 |
(b) Not applicable
| ITEM 2. | CODE OF ETHICS. |
(a) The Registrant has adopted a code of ethics that applies to its principal executive officers and principal financial and accounting officer.
(c) N/A
(d) N/A
(f) Pursuant to Item 19(a) (1), the Registrant is attaching as an exhibit a copy of its code of ethics that applies to its principal executive officers and principal financial and accounting officer.
| ITEM 3. | AUDIT COMMITTEE FINANCIAL EXPERT. |
The Board of Trustees of the Registrant has determined that Stephen R. Gross, possesses the technical attributes identified in Item 3 to Form N-CSR to qualify as an "audit committee financial expert," and has designated Stephen R. Gross as the Audit Committee's financial expert. Stephen R. Gross is an "independent" Trustee pursuant to paragraph (a)(2) of Item 3 to Form N-CSR.
Under applicable securities laws, a person determined to be an audit committee financial expert will not be deemed an "expert" for any purpose, including without limitation for the purposes of Section 11 of the Securities Act of 1933, as a result of being designated or identified as an audit committee financial expert. The designation or identification of a person as an audit committee financial expert does not impose on such person any duties, obligations, or liabilities greater than the duties, obligations, and liabilities imposed on such person as a member of the audit committee and board of directors in the absence of such designation or identification. The designation or identification of a person as an audit committee financial expert does not affect the duties, obligations, or liability of any other member of the audit committee or board of directors.
| ITEM 4. | PRINCIPAL ACCOUNTANT FEES AND SERVICES. |
a) Audit Fees. The aggregate fees billed in the last two fiscal years ending October 31, 2024 and October 31, 2025 (the "Reporting Periods") for professional services rendered by the Registrant's principal accountant (the "Auditor") for the audit of the Registrant's annual financial statements, or services that are normally provided by the Auditor in connection with the statutory and regulatory filings or engagements for the Reporting Periods, were $350,718 in October 31, 2024 and $354,225 in October 31, 2025.
b) Audit-Related Fees. The aggregate fees billed in the Reporting Periods for assurance and related services by the Auditor that are reasonably related to the performance of the Registrant's financial statements were $0 in October 31, 2024 and $0 in October 31, 2025.
(c) Tax Fees. The aggregate fees billed in the Reporting Periods for professional services rendered by the Auditor for tax compliance, tax advice and tax planning ("Tax Services") were $100,500 in October 31, 2024 and $100,500 in October 31, 2025. These services consisted of (i) review or preparation of U.S. federal, state, local and excise tax returns; (ii) U.S. federal, state and local tax planning, advice and assistance regarding statutory, regulatory or administrative developments, and (iii) tax advice regarding tax qualification matters and/or treatment of various financial instruments held or proposed to be acquired or held.
There were no fees billed for tax services by the Auditors to the Registrant's investment manager and any entity controlling, controlled by, or under common control with the investment manager that provides ongoing services to the Registrant ("Service Affiliates") during the Reporting Periods that required pre-approval by the Audit Committee.
d) All Other Fees. The aggregate fees billed in the Reporting Periods for products and services provided by the Auditor to the Registrant, other than the services reported in paragraphs (a) through (c) of this item, were $0 in October 31, 2024 and $0 in October 31, 2025.
There were no other non-audit services rendered by the Auditor to the Service Affiliates requiring pre-approval by the Audit Committee in the Reporting Periods.
(e) Audit Committee's pre-approval policies and procedures described in paragraph (c) (7) of Rule 2-01 of Regulation S-X.
(1) The Charter for the Audit Committee (the "Committee") of the Board of each registered investment company (the "Fund") advised by the Registrant's investment manager or one of their affiliates (each, an "Adviser") requires that the Committee shall approve (a) all audit and permissible non-audit services to be provided to the Fund and (b) all permissible non-audit services to be provided by the Fund's independent auditors to the Adviser and any service providers controlling, controlled by or under common control with the Adviser that provide ongoing services to the Fund ("Covered Service Providers") if the engagement relates directly to the operations and financial reporting of the Fund. The Committee may implement policies and procedures by which such services are approved other than by the full Committee.
The Committee shall not approve non-audit services that the Committee believes may impair the independence of the auditors. As of the date of the approval of this Audit Committee Charter, permissible non-audit services include any professional services (including tax services), that are not prohibited services as described below, provided to the Fund by the independent auditors, other than those provided to the Fund in connection with an audit or a review of the financial statements of the Fund. Permissible non-audit services may not include: (i) bookkeeping or other services related to the accounting records or financial statements of the Fund; (ii) financial information systems design and implementation; (iii) appraisal or valuation services, fairness opinions or contribution-in-kind reports; (iv) actuarial services; (v) internal audit outsourcing services; (vi) management functions or human resources; (vii) broker or dealer, investment adviser or investment banking services; (viii) legal services and expert services unrelated to the audit; and (ix) any other service the Public Company Accounting Oversight Board determines, by regulation, is impermissible.
Pre-approval by the Committee of any permissible non-audit services is not required so long as: (i) the aggregate amount of all such permissible non-audit services provided to the Fund, the Adviser and the Covered Service Providers constitutes not more than 5% of the total amount of revenues paid to the independent auditors during the fiscal year in which the permissible non-audit services are provided to (a) the Fund, (b) the Adviser and (c) any entity controlling, controlled by or under common control with the Adviser that provides ongoing services to the Fund during the fiscal year in which the services are provided that would have to be approved by the Committee; (ii) the permissible non-audit services were not recognized by the Fund at the time of the engagement to be non-audit services; and (iii) such services are promptly brought to the attention of the Committee and approved by the Committee (or its delegate(s)) prior to the completion of the audit.
(2) None of the services described in paragraphs (b) through (d) of this Item were performed in reliance on paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.
(f) Not applicable.
(g) Non-audit fees billed by the Auditor for services rendered to the Registrant and the Service Affiliates during the reporting period were $811,835 in October 31, 2024 and $870,024 in October 31, 2025.
(h) Yes. The Registrant's Audit Committee has considered whether the provision of non-audit services that were rendered to Service Affiliates, which were not pre-approved (not requiring pre-approval), is compatible with maintaining the Auditor's independence. All services provided by the Auditor to the Registrant or to the Service Affiliates, which were required to be pre-approved, were pre-approved as required.
(i) Not applicable.
(j) Not applicable.
| ITEM 5. | AUDIT COMMITTEE OF LISTED REGISTRANTS. |
Not applicable.
| ITEM 6. | SCHEDULE OF INVESTMENTS. |
| (a) | Please see schedule of investments contained in the Financial Statements and Financial Highlights included under Item 7 of this Form N-CSR. |
| (b) | Not applicable. |
| ITEM 7. | FINANCIAL STATEMENTS AND FINANCIAL HIGHLIGHTS FOR OPEN-END MANAGEMENT INVESTMENT COMPANIES. |
|
Schedule of Investments
|
1
|
|
Statement of Assets and Liabilities
|
5
|
|
Statement of Operations
|
7
|
|
Statements of Changes in Net Assets
|
8
|
|
Financial Highlights
|
9
|
|
Notes to Financial Statements
|
15
|
|
Report of Independent Registered Public Accounting Firm
|
26
|
|
Important Tax Information
|
27
|
|
Changes in and Disagreements with Accountants
|
28
|
|
Results of Meeting(s) of Shareholders
|
28
|
|
Remuneration Paid to Directors, Officers and Others
|
28
|
|
Board Approval of Management and Subadvisory Agreements
|
29
|
|
Security
|
|
|
|
Shares
|
Value
|
|
Common Stocks - 98.3%
|
|||||
|
Communication Services - 2.1%
|
|||||
|
Entertainment - 1.3%
|
|||||
|
Live Nation Entertainment Inc.
|
136,000
|
$20,336,080
*
|
|||
|
Interactive Media & Services - 0.8%
|
|||||
|
Pinterest Inc., Class A Shares
|
400,000
|
13,240,000
*
|
|||
|
|
|||||
|
Total Communication Services
|
33,576,080
|
||||
|
Consumer Discretionary - 11.1%
|
|||||
|
Diversified Consumer Services - 1.3%
|
|||||
|
Service Corp. International
|
246,000
|
20,543,460
|
|||
|
Hotels, Restaurants & Leisure - 4.7%
|
|||||
|
Churchill Downs Inc.
|
250,000
|
24,800,000
|
|||
|
Expedia Group Inc.
|
117,000
|
25,740,000
|
|||
|
Light & Wonder Inc.
|
350,000
|
25,445,000
*
|
|||
|
Total Hotels, Restaurants & Leisure
|
75,985,000
|
||||
|
Household Durables - 1.6%
|
|||||
|
Mohawk Industries Inc.
|
230,000
|
26,137,200
*
|
|||
|
Specialty Retail - 3.5%
|
|||||
|
Chewy Inc., Class A Shares
|
1,125,000
|
37,935,000
*
|
|||
|
Ross Stores Inc.
|
123,000
|
19,547,160
|
|||
|
Total Specialty Retail
|
57,482,160
|
||||
|
|
|||||
|
Total Consumer Discretionary
|
180,147,820
|
||||
|
Consumer Staples - 5.5%
|
|||||
|
Consumer Staples Distribution & Retail - 5.5%
|
|||||
|
Casey's General Stores Inc.
|
95,000
|
48,753,050
|
|||
|
Performance Food Group Co.
|
425,000
|
41,114,500
*
|
|||
|
|
|||||
|
Total Consumer Staples
|
89,867,550
|
||||
|
Energy - 6.0%
|
|||||
|
Energy Equipment & Services - 2.5%
|
|||||
|
Archrock Inc.
|
575,000
|
14,530,250
|
|||
|
Baker Hughes Co.
|
526,000
|
25,463,660
|
|||
|
Total Energy Equipment & Services
|
39,993,910
|
||||
|
Oil, Gas & Consumable Fuels - 3.5%
|
|||||
|
Diamondback Energy Inc.
|
75,000
|
10,739,250
|
|||
|
EQT Corp.
|
875,000
|
46,882,500
|
|||
|
Total Oil, Gas & Consumable Fuels
|
57,621,750
|
||||
|
|
|||||
|
Total Energy
|
97,615,660
|
||||
|
Financials - 12.3%
|
|||||
|
Banks - 2.8%
|
|||||
|
Fifth Third Bancorp
|
300,000
|
12,486,000
|
|||
|
Security
|
|
|
|
Shares
|
Value
|
|
|
|||||
|
Banks - continued
|
|||||
|
PNC Financial Services Group Inc.
|
112,000
|
$20,445,600
|
|||
|
UMB Financial Corp.
|
116,000
|
12,398,080
|
|||
|
Total Banks
|
45,329,680
|
||||
|
Capital Markets - 5.4%
|
|||||
|
Blue Owl Capital Inc.
|
1,300,000
|
20,501,000
|
|||
|
Coinbase Global Inc., Class A Shares
|
36,000
|
12,376,080
*
|
|||
|
Houlihan Lokey Inc.
|
120,000
|
21,489,600
|
|||
|
Raymond James Financial Inc.
|
215,000
|
34,114,050
|
|||
|
Total Capital Markets
|
88,480,730
|
||||
|
Insurance - 4.1%
|
|||||
|
Arch Capital Group Ltd.
|
330,000
|
28,482,300
|
|||
|
Hartford Insurance Group Inc.
|
304,000
|
37,750,720
|
|||
|
Total Insurance
|
66,233,020
|
||||
|
|
|||||
|
Total Financials
|
200,043,430
|
||||
|
Health Care - 11.2%
|
|||||
|
Biotechnology - 2.6%
|
|||||
|
Alnylam Pharmaceuticals Inc.
|
32,000
|
14,593,280
*
|
|||
|
Argenx SE, ADR
|
34,000
|
27,829,000
*
|
|||
|
Total Biotechnology
|
42,422,280
|
||||
|
Health Care Equipment & Supplies - 3.9%
|
|||||
|
Insulet Corp.
|
56,000
|
17,528,560
*
|
|||
|
Penumbra Inc.
|
68,000
|
15,461,160
*
|
|||
|
STERIS PLC
|
131,000
|
30,876,700
|
|||
|
Total Health Care Equipment & Supplies
|
63,866,420
|
||||
|
Health Care Providers & Services - 1.8%
|
|||||
|
Tenet Healthcare Corp.
|
140,000
|
28,908,600
*
|
|||
|
Life Sciences Tools & Services - 2.9%
|
|||||
|
Bio-Techne Corp.
|
435,000
|
27,217,950
|
|||
|
ICON PLC
|
119,000
|
20,446,580
*
|
|||
|
Total Life Sciences Tools & Services
|
47,664,530
|
||||
|
|
|||||
|
Total Health Care
|
182,861,830
|
||||
|
Industrials - 19.8%
|
|||||
|
Aerospace & Defense - 2.1%
|
|||||
|
Axon Enterprise Inc.
|
11,000
|
8,054,530
*
|
|||
|
CAE Inc.
|
925,000
|
25,955,500
*
|
|||
|
Total Aerospace & Defense
|
34,010,030
|
||||
|
Building Products - 2.7%
|
|||||
|
Resideo Technologies Inc.
|
1,050,000
|
44,940,000
*
|
|||
|
Commercial Services & Supplies - 3.7%
|
|||||
|
Casella Waste Systems Inc., Class A Shares
|
190,000
|
16,828,300
*
|
|||
|
Security
|
|
|
|
Shares
|
Value
|
|
|
|||||
|
Commercial Services & Supplies - continued
|
|||||
|
Clean Harbors Inc.
|
207,000
|
$43,575,570
*
|
|||
|
Total Commercial Services & Supplies
|
60,403,870
|
||||
|
Construction & Engineering - 4.7%
|
|||||
|
API Group Corp.
|
1,350,000
|
49,707,000
*
|
|||
|
WillScot Holdings Corp.
|
1,205,000
|
26,208,750
|
|||
|
Total Construction & Engineering
|
75,915,750
|
||||
|
Electrical Equipment - 4.2%
|
|||||
|
Regal Rexnord Corp.
|
280,000
|
39,449,200
|
|||
|
Vertiv Holdings Co., Class A Shares
|
150,000
|
28,929,000
|
|||
|
Total Electrical Equipment
|
68,378,200
|
||||
|
Trading Companies & Distributors - 2.4%
|
|||||
|
Ferguson Enterprises Inc.
|
130,000
|
32,305,000
|
|||
|
QXO Inc.
|
400,000
|
7,068,000
*
|
|||
|
Total Trading Companies & Distributors
|
39,373,000
|
||||
|
|
|||||
|
Total Industrials
|
323,020,850
|
||||
|
Information Technology - 14.5%
|
|||||
|
Electronic Equipment, Instruments & Components - 3.0%
|
|||||
|
Teledyne Technologies Inc.
|
92,000
|
48,467,440
*
|
|||
|
Semiconductors & Semiconductor Equipment - 3.1%
|
|||||
|
Microchip Technology Inc.
|
425,000
|
26,528,500
|
|||
|
Qorvo Inc.
|
255,000
|
24,204,600
*
|
|||
|
Total Semiconductors & Semiconductor Equipment
|
50,733,100
|
||||
|
Software - 8.4%
|
|||||
|
AppLovin Corp., Class A Shares
|
59,000
|
37,602,470
*
|
|||
|
Bentley Systems Inc., Class B Shares
|
250,000
|
12,707,500
|
|||
|
Dynatrace Inc.
|
600,000
|
30,342,000
*
|
|||
|
PTC Inc.
|
125,000
|
24,817,500
*
|
|||
|
Rubrik Inc., Class A Shares
|
300,000
|
22,581,000
*
|
|||
|
SailPoint Inc.
|
422,066
|
9,150,391
*
|
|||
|
Total Software
|
137,200,861
|
||||
|
|
|||||
|
Total Information Technology
|
236,401,401
|
||||
|
Materials - 3.9%
|
|||||
|
Containers & Packaging - 3.9%
|
|||||
|
Crown Holdings Inc.
|
350,000
|
34,013,000
|
|||
|
International Paper Co.
|
783,000
|
30,255,120
|
|||
|
|
|||||
|
Total Materials
|
64,268,120
|
||||
|
Real Estate - 5.4%
|
|||||
|
Health Care REITs - 0.8%
|
|||||
|
Alexandria Real Estate Equities Inc.
|
226,000
|
13,157,720
|
|||
|
Security
|
|
|
|
Shares
|
Value
|
|
|
|||||
|
Real Estate Management & Development - 2.1%
|
|||||
|
CoStar Group Inc.
|
294,000
|
$20,230,140
*
|
|||
|
Jones Lang LaSalle Inc.
|
47,000
|
14,339,230
*
|
|||
|
Total Real Estate Management & Development
|
34,569,370
|
||||
|
Retail REITs - 1.4%
|
|||||
|
NNN REIT Inc.
|
575,000
|
23,264,500
|
|||
|
Specialized REITs - 1.1%
|
|||||
|
SBA Communications Corp.
|
90,000
|
17,233,200
|
|||
|
|
|||||
|
Total Real Estate
|
88,224,790
|
||||
|
Utilities - 6.5%
|
|||||
|
Electric Utilities - 2.8%
|
|||||
|
PPL Corp.
|
1,230,000
|
44,919,600
|
|||
|
Independent Power and Renewable Electricity Producers - 1.9%
|
|||||
|
Vistra Corp.
|
161,000
|
30,316,300
|
|||
|
Multi-Utilities - 1.8%
|
|||||
|
DTE Energy Co.
|
220,000
|
29,818,800
|
|||
|
|
|||||
|
Total Utilities
|
105,054,700
|
||||
|
Total Investments before Short-Term Investments (Cost - $1,065,666,367)
|
1,601,082,231
|
||||
|
|
|
Rate
|
|
|
|
|
Short-Term Investments - 1.8%
|
|||||
|
JPMorgan 100% U.S. Treasury Securities Money Market
Fund, Institutional Class
|
3.833%
|
14,778,435
|
14,778,435
(a)
|
||
|
Western Asset Premier Institutional U.S. Treasury
Reserves, Premium Shares
|
3.896%
|
14,778,436
|
14,778,436
(a)(b)
|
||
|
|
|||||
|
Total Short-Term Investments (Cost - $29,556,871)
|
29,556,871
|
||||
|
Total Investments - 100.1% (Cost - $1,095,223,238)
|
1,630,639,102
|
||||
|
Liabilities in Excess of Other Assets - (0.1)%
|
(1,348,447
)
|
||||
|
Total Net Assets - 100.0%
|
$1,629,290,655
|
||||
|
*
|
Non-income producing security.
|
|
(a)
|
Rate shown is one-day yield as of the end of the reporting period.
|
|
(b)
|
In this instance, as defined in the Investment Company Act of 1940, an "Affiliated Company"represents Fund
ownership of at least 5% of the outstanding voting securities of an issuer, or a company which is under common
ownership or control with the Fund. At October 31, 2025, the total market value of investments in Affiliated
Companies was $14,778,436 and the cost was $14,778,436 (Note 8).
|
|
Abbreviation(s) used in this schedule:
|
||
|
ADR
|
-
|
American Depositary Receipts
|
|
REIT
|
-
|
Real Estate Investment Trust
|
|
Assets:
|
|
|
Investments in unaffiliated securities, at value (Cost - $1,080,444,802)
|
$1,615,860,666
|
|
Investments in affiliated securities, at value (Cost - $14,778,436)
|
14,778,436
|
|
Cash
|
111
|
|
Receivable for Fund shares sold
|
744,335
|
|
Dividends receivable from unaffiliated investments
|
732,595
|
|
Dividends receivable from affiliated investments
|
34,143
|
|
Prepaid expenses
|
43,464
|
|
Total Assets
|
1,632,193,750
|
|
Liabilities:
|
|
|
Investment management fee payable
|
1,090,356
|
|
Payable for Fund shares repurchased
|
936,067
|
|
Transfer agent fees payable
|
418,849
|
|
Service and/or distribution fees payable
|
282,116
|
|
Trustees' fees payable
|
2,333
|
|
Accrued expenses
|
173,374
|
|
Total Liabilities
|
2,903,095
|
|
Total Net Assets
|
$1,629,290,655
|
|
Net Assets:
|
|
|
Par value (Note 7)
|
$445
|
|
Paid-in capital in excess of par value
|
968,650,519
|
|
Total distributable earnings (loss)
|
660,639,691
|
|
Total Net Assets
|
$1,629,290,655
|
|
Net Assets:
|
|
|
Class 1
|
$2,232,745
|
|
Class A
|
$1,140,006,293
|
|
Class C
|
$7,758,295
|
|
Class R
|
$56,012,464
|
|
Class I
|
$241,495,462
|
|
Class IS
|
$181,785,396
|
|
Shares Outstanding:
|
|
|
Class 1
|
58,520
|
|
Class A
|
32,381,341
|
|
Class C
|
343,543
|
|
Class R
|
1,689,867
|
|
Class I
|
5,753,020
|
|
Class IS
|
4,267,165
|
|
Net Asset Value:
|
|
|
Class 1 (and redemption price)
|
$38.15
|
|
Class A (and redemption price)
|
$35.21
|
|
Class C*
|
$22.58
|
|
Class R (and redemption price)
|
$33.15
|
|
Class I (and redemption price)
|
$41.98
|
|
Class IS (and redemption price)
|
$42.60
|
|
Maximum Public Offering Price Per Share:
|
|
|
Class A (based on maximum initial sales charge of 5.50%)
|
$37.26
|
|
*
|
Redemption price per share is NAV of Class C shares reduced by a 1.00% CDSC if shares are redeemed within
one year from purchase payment (Note 2).
|
|
Investment Income:
|
|
|
Dividends from unaffiliated investments
|
$18,276,946
|
|
Dividends from affiliated investments
|
598,639
|
|
Total Investment Income
|
18,875,585
|
|
Expenses:
|
|
|
Investment management fee (Note 2)
|
12,351,359
|
|
Service and/or distribution fees (Notes 2 and 5)
|
3,294,803
|
|
Transfer agent fees (Notes 2 and 5)
|
1,998,886
|
|
Registration fees
|
114,223
|
|
Legal fees
|
87,878
|
|
Fund accounting fees
|
82,464
|
|
Trustees' fees
|
78,749
|
|
Audit and tax fees
|
42,527
|
|
Commitment fees (Note 9)
|
14,948
|
|
Insurance
|
10,987
|
|
Shareholder reports
|
9,732
|
|
Custody fees
|
9,405
|
|
Interest expense
|
8,664
|
|
Miscellaneous expenses
|
21,588
|
|
Total Expenses
|
18,126,213
|
|
Less: Fee waivers and/or expense reimbursements (Notes 2 and 5)
|
(147,969
)
|
|
Net Expenses
|
17,978,244
|
|
Net Investment Income
|
897,341
|
|
Realized and Unrealized Gain (Loss) on Investments and Foreign Currency Transactions (Notes 1
and 3):
|
|
|
Net Realized Gain (Loss) From:
|
|
|
Investment transactions in unaffiliated securities
|
144,199,072
|
|
Foreign currency transactions
|
(21,041
)
|
|
Net Realized Gain
|
144,178,031
|
|
Change in Net Unrealized Appreciation (Depreciation) From Unaffiliated
Investments
|
(12,614,999
)
|
|
Net Gain on Investments and Foreign Currency Transactions
|
131,563,032
|
|
Increase in Net Assets From Operations
|
$132,460,373
|
|
For the Years Ended October 31,
|
2025
|
2024
|
|
Operations:
|
||
|
Net investment income
|
$897,341
|
$1,381,394
|
|
Net realized gain
|
144,178,031
|
161,160,085
|
|
Change in net unrealized appreciation (depreciation)
|
(12,614,999
)
|
233,041,310
|
|
Increase in Net Assets From Operations
|
132,460,373
|
395,582,789
|
|
Distributions to Shareholders From (Notes 1 and 6):
|
||
|
Total distributable earnings
|
(137,960,387
)
|
(35,515,061
)
|
|
Decrease in Net Assets From Distributions to Shareholders
|
(137,960,387
)
|
(35,515,061
)
|
|
Fund Share Transactions (Note 7):
|
||
|
Net proceeds from sale of shares
|
139,261,121
|
212,292,518
|
|
Reinvestment of distributions
|
133,789,715
|
34,512,992
|
|
Cost of shares repurchased
|
(363,223,990
)
|
(638,582,406
)
|
|
Decrease in Net Assets From Fund Share Transactions
|
(90,173,154
)
|
(391,776,896
)
|
|
Decrease in Net Assets
|
(95,673,168
)
|
(31,709,168
)
|
|
Net Assets:
|
||
|
Beginning of year
|
1,724,963,823
|
1,756,672,991
|
|
End of year
|
$1,629,290,655
|
$1,724,963,823
|
|
For a share of each class of beneficial interest outstanding throughout each year ended October 31:
|
|||||
|
Class 1 Shares1
|
2025
|
2024
|
2023
|
2022
|
2021
|
|
Net asset value, beginning of year
|
$38.03
|
$31.34
|
$33.52
|
$49.24
|
$35.25
|
|
Income (loss) from operations:
|
|||||
|
Net investment income
|
0.11
|
0.10
|
0.10
|
0.06
|
0.04
|
|
Net realized and unrealized gain (loss)
|
3.07
|
7.25
|
(0.72
)
|
(10.39
)
|
16.62
|
|
Total income (loss) from operations
|
3.18
|
7.35
|
(0.62)
|
(10.33)
|
16.66
|
|
Less distributions from:
|
|||||
|
Net investment income
|
(0.12
)
|
(0.05
)
|
(0.09
)
|
-
|
(0.00
)2
|
|
Net realized gains
|
(2.94
)
|
(0.61
)
|
(1.47
)
|
(5.39
)
|
(2.67
)
|
|
Total distributions
|
(3.06
)
|
(0.66
)
|
(1.56
)
|
(5.39
)
|
(2.67
)
|
|
Net asset value, end of year
|
$38.15
|
$38.03
|
$31.34
|
$33.52
|
$49.24
|
|
Total return3
|
8.34
%
|
23.64
%
|
(2.12
)%
|
(23.33
)%
|
49.59
%
|
|
Net assets, end of year (000s)
|
$2,233
|
$2,722
|
$3,065
|
$3,294
|
$4,556
|
|
Ratios to average net assets:
|
|||||
|
Gross expenses
|
0.85
%
|
0.84
%
|
0.84
%
|
0.82
%
|
0.82
%
|
|
Net expenses4,5
|
0.84
|
0.83
|
0.83
|
0.82
|
0.82
|
|
Net investment income
|
0.29
|
0.29
|
0.29
|
0.14
|
0.09
|
|
Portfolio turnover rate
|
29
%
|
36
%
|
38
%
|
23
%
|
30
%
|
|
1
|
Per share amounts have been calculated using the average shares method.
|
|
2
|
Amount represents less than $0.005 or greater than $(0.005) per share.
|
|
3
|
Performance figures may reflect compensating balance arrangements, fee waivers and/or expense reimbursements.
In the absence of compensating balance arrangements, fee waivers and/or expense reimbursements, the total
return would have been lower. Past performance is no guarantee of future results.
|
|
4
|
As a result of an expense limitation arrangement, the ratio of total annual fund operating expenses for Class 1
shares did not exceed the ratio of total annual fund operating expenses for Class A shares. This expense limitation
arrangement cannot be terminated prior to December 31, 2027 without the Board of Trustees' consent. In addition,
the manager has agreed to waive the Fund's management fee to an extent sufficient to offset the net management
fee payable in connection with any investment in an affiliated money market fund.
|
|
5
|
Reflects fee waivers and/or expense reimbursements.
|
|
For a share of each class of beneficial interest outstanding throughout each year ended October 31:
|
|||||
|
Class A Shares1
|
2025
|
2024
|
2023
|
2022
|
2021
|
|
Net asset value, beginning of year
|
$35.31
|
$29.19
|
$31.33
|
$46.52
|
$33.53
|
|
Income (loss) from operations:
|
|||||
|
Net investment loss
|
(0.01
)
|
(0.01
)
|
(0.01
)
|
(0.06
)
|
(0.09
)
|
|
Net realized and unrealized gain (loss)
|
2.87
|
6.74
|
(0.66
)
|
(9.74
)
|
15.75
|
|
Total income (loss) from operations
|
2.86
|
6.73
|
(0.67)
|
(9.80)
|
15.66
|
|
Less distributions from:
|
|||||
|
Net investment income
|
(0.02
)
|
-
|
-
|
-
|
-
|
|
Net realized gains
|
(2.94
)
|
(0.61
)
|
(1.47
)
|
(5.39
)
|
(2.67
)
|
|
Total distributions
|
(2.96
)
|
(0.61
)
|
(1.47
)
|
(5.39
)
|
(2.67
)
|
|
Net asset value, end of year
|
$35.21
|
$35.31
|
$29.19
|
$31.33
|
$46.52
|
|
Total return2
|
8.05
%
|
23.25
%
|
(2.43
)%
|
(23.58
)%
|
49.11
%
|
|
Net assets, end of year (millions)
|
$1,140
|
$1,155
|
$1,023
|
$1,087
|
$1,411
|
|
Ratios to average net assets:
|
|||||
|
Gross expenses
|
1.15
%
|
1.16
%
|
1.16
%
|
1.14
%
|
1.13
%
|
|
Net expenses3,4
|
1.14
|
1.15
|
1.15
|
1.14
|
1.13
|
|
Net investment loss
|
(0.03
)
|
(0.03
)
|
(0.03
)
|
(0.18
)
|
(0.22
)
|
|
Portfolio turnover rate
|
29
%
|
36
%
|
38
%
|
23
%
|
30
%
|
|
1
|
Per share amounts have been calculated using the average shares method.
|
|
2
|
Performance figures, exclusive of sales charges, may reflect compensating balance arrangements, fee waivers
and/or expense reimbursements. In the absence of compensating balance arrangements, fee waivers and/or
expense reimbursements, the total return would have been lower. Past performance is no guarantee of future
results.
|
|
3
|
As a result of an expense limitation arrangement, the ratio of total annual fund operating expenses, other than
interest, brokerage commissions, taxes, extraordinary expenses and acquired fund fees and expenses, to average
net assets of Class A shares did not exceed 1.20%. This expense limitation arrangement cannot be terminated
prior to December 31, 2027 without the Board of Trustees' consent. In addition, the manager has agreed to waive
the Fund's management fee to an extent sufficient to offset the net management fee payable in connection with
any investment in an affiliated money market fund.
|
|
4
|
Reflects fee waivers and/or expense reimbursements.
|
|
For a share of each class of beneficial interest outstanding throughout each year ended October 31:
|
|||||
|
Class C Shares1
|
2025
|
2024
|
2023
|
2022
|
2021
|
|
Net asset value, beginning of year
|
$23.77
|
$19.97
|
$22.03
|
$34.56
|
$25.68
|
|
Income (loss) from operations:
|
|||||
|
Net investment loss
|
(0.17
)
|
(0.17
)
|
(0.16
)
|
(0.24
)
|
(0.29
)
|
|
Net realized and unrealized gain (loss)
|
1.92
|
4.58
|
(0.43
)
|
(6.90
)
|
11.84
|
|
Total income (loss) from operations
|
1.75
|
4.41
|
(0.59)
|
(7.14)
|
11.55
|
|
Less distributions from:
|
|||||
|
Net realized gains
|
(2.94
)
|
(0.61
)
|
(1.47
)
|
(5.39
)
|
(2.67
)
|
|
Total distributions
|
(2.94
)
|
(0.61
)
|
(1.47
)
|
(5.39
)
|
(2.67
)
|
|
Net asset value, end of year
|
$22.58
|
$23.77
|
$19.97
|
$22.03
|
$34.56
|
|
Total return2
|
7.22
%
|
22.34
%
|
(3.12
)%
|
(24.12
)%
|
48.03
%
|
|
Net assets, end of year (000s)
|
$7,758
|
$10,928
|
$12,982
|
$19,227
|
$30,728
|
|
Ratios to average net assets:
|
|||||
|
Gross expenses
|
1.89
%
|
1.88
%
|
1.87
%
|
1.87
%
|
1.87
%
|
|
Net expenses3,4
|
1.88
|
1.88
|
1.86
|
1.87
|
1.87
|
|
Net investment loss
|
(0.74
)
|
(0.75
)
|
(0.73
)
|
(0.93
)
|
(0.96
)
|
|
Portfolio turnover rate
|
29
%
|
36
%
|
38
%
|
23
%
|
30
%
|
|
1
|
Per share amounts have been calculated using the average shares method.
|
|
2
|
Performance figures, exclusive of CDSC, may reflect compensating balance arrangements, fee waivers and/or
expense reimbursements. In the absence of compensating balance arrangements, fee waivers and/or expense
reimbursements, the total return would have been lower. Past performance is no guarantee of future results.
|
|
3
|
As a result of an expense limitation arrangement, the ratio of total annual fund operating expenses, other than
interest, brokerage commissions, taxes, extraordinary expenses and acquired fund fees and expenses, to average
net assets of Class C shares did not exceed 1.95%. This expense limitation arrangement cannot be terminated
prior to December 31, 2027 without the Board of Trustees' consent. In addition, the manager has agreed to waive
the Fund's management fee to an extent sufficient to offset the net management fee payable in connection with
any investment in an affiliated money market fund.
|
|
4
|
Reflects fee waivers and/or expense reimbursements.
|
|
For a share of each class of beneficial interest outstanding throughout each year ended October 31:
|
|||||
|
Class R Shares1
|
2025
|
2024
|
2023
|
2022
|
2021
|
|
Net asset value, beginning of year
|
$33.49
|
$27.79
|
$29.98
|
$44.88
|
$32.53
|
|
Income (loss) from operations:
|
|||||
|
Net investment loss
|
(0.11
)
|
(0.11
)
|
(0.10
)
|
(0.17
)
|
(0.21
)
|
|
Net realized and unrealized gain (loss)
|
2.71
|
6.42
|
(0.62
)
|
(9.34
)
|
15.23
|
|
Total income (loss) from operations
|
2.60
|
6.31
|
(0.72)
|
(9.51)
|
15.02
|
|
Less distributions from:
|
|||||
|
Net realized gains
|
(2.94
)
|
(0.61
)
|
(1.47
)
|
(5.39
)
|
(2.67
)
|
|
Total distributions
|
(2.94
)
|
(0.61
)
|
(1.47
)
|
(5.39
)
|
(2.67
)
|
|
Net asset value, end of year
|
$33.15
|
$33.49
|
$27.79
|
$29.98
|
$44.88
|
|
Total return2
|
7.69
%
|
22.90
%
|
(2.71
)%
|
(23.82
)%
|
48.63
%
|
|
Net assets, end of year (000s)
|
$56,012
|
$61,913
|
$53,438
|
$57,554
|
$71,031
|
|
Ratios to average net assets:
|
|||||
|
Gross expenses
|
1.46
%
|
1.46
%
|
1.46
%
|
1.45
%
|
1.46
%
|
|
Net expenses3,4
|
1.45
|
1.45
|
1.45
|
1.45
|
1.45
|
|
Net investment loss
|
(0.33
)
|
(0.33
)
|
(0.32
)
|
(0.48
)
|
(0.53
)
|
|
Portfolio turnover rate
|
29
%
|
36
%
|
38
%
|
23
%
|
30
%
|
|
1
|
Per share amounts have been calculated using the average shares method.
|
|
2
|
Performance figures may reflect compensating balance arrangements, fee waivers and/or expense reimbursements.
In the absence of compensating balance arrangements, fee waivers and/or expense reimbursements, the total
return would have been lower. Past performance is no guarantee of future results.
|
|
3
|
As a result of an expense limitation arrangement, the ratio of total annual fund operating expenses, other than
interest, brokerage commissions, taxes, extraordinary expenses and acquired fund fees and expenses, to average
net assets of Class R shares did not exceed 1.45%. This expense limitation arrangement cannot be terminated
prior to December 31, 2027 without the Board of Trustees' consent. In addition, the manager has agreed to waive
the Fund's management fee to an extent sufficient to offset the net management fee payable in connection with
any investment in an affiliated money market fund.
|
|
4
|
Reflects fee waivers and/or expense reimbursements.
|
|
For a share of each class of beneficial interest outstanding throughout each year ended October 31:
|
|||||
|
Class I Shares1
|
2025
|
2024
|
2023
|
2022
|
2021
|
|
Net asset value, beginning of year
|
$41.54
|
$34.18
|
$36.40
|
$53.02
|
$37.79
|
|
Income (loss) from operations:
|
|||||
|
Net investment income
|
0.12
|
0.11
|
0.10
|
0.05
|
0.03
|
|
Net realized and unrealized gain (loss)
|
3.37
|
7.89
|
(0.78
)
|
(11.28
)
|
17.87
|
|
Total income (loss) from operations
|
3.49
|
8.00
|
(0.68)
|
(11.23)
|
17.90
|
|
Less distributions from:
|
|||||
|
Net investment income
|
(0.11
)
|
(0.03
)
|
(0.07
)
|
-
|
(0.00
)2
|
|
Net realized gains
|
(2.94
)
|
(0.61
)
|
(1.47
)
|
(5.39
)
|
(2.67
)
|
|
Total distributions
|
(3.05
)
|
(0.64
)
|
(1.54
)
|
(5.39
)
|
(2.67
)
|
|
Net asset value, end of year
|
$41.98
|
$41.54
|
$34.18
|
$36.40
|
$53.02
|
|
Total return3
|
8.38
%
|
23.60
%
|
(2.11
)%
|
(23.36
)%
|
49.53
%
|
|
Net assets, end of year (millions)
|
$241
|
$294
|
$358
|
$414
|
$545
|
|
Ratios to average net assets:
|
|||||
|
Gross expenses
|
0.84
%
|
0.88
%
|
0.86
%
|
0.86
%
|
0.84
%
|
|
Net expenses4,5
|
0.83
|
0.85
|
0.85
|
0.85
|
0.84
|
|
Net investment income
|
0.29
|
0.27
|
0.28
|
0.11
|
0.07
|
|
Portfolio turnover rate
|
29
%
|
36
%
|
38
%
|
23
%
|
30
%
|
|
1
|
Per share amounts have been calculated using the average shares method.
|
|
2
|
Amount represents less than $0.005 or greater than $(0.005) per share.
|
|
3
|
Performance figures may reflect compensating balance arrangements, fee waivers and/or expense reimbursements.
In the absence of compensating balance arrangements, fee waivers and/or expense reimbursements, the total
return would have been lower. Past performance is no guarantee of future results.
|
|
4
|
As a result of an expense limitation arrangement, the ratio of total annual fund operating expenses, other than
interest, brokerage commissions, taxes, extraordinary expenses and acquired fund fees and expenses, to average
net assets of Class I shares did not exceed 0.85%. This expense limitation arrangement cannot be terminated prior
to December 31, 2027 without the Board of Trustees' consent. In addition, the manager has agreed to waive the
Fund's management fee to an extent sufficient to offset the net management fee payable in connection with any
investment in an affiliated money market fund.
|
|
5
|
Reflects fee waivers and/or expense reimbursements.
|
|
For a share of each class of beneficial interest outstanding throughout each year ended October 31:
|
|||||
|
Class IS Shares1
|
2025
|
2024
|
2023
|
2022
|
2021
|
|
Net asset value, beginning of year
|
$42.13
|
$34.65
|
$36.91
|
$53.63
|
$38.17
|
|
Income (loss) from operations:
|
|||||
|
Net investment income
|
0.15
|
0.16
|
0.14
|
0.09
|
0.08
|
|
Net realized and unrealized gain (loss)
|
3.42
|
8.00
|
(0.81
)
|
(11.42
)
|
18.06
|
|
Total income (loss) from operations
|
3.57
|
8.16
|
(0.67)
|
(11.33)
|
18.14
|
|
Less distributions from:
|
|||||
|
Net investment income
|
(0.16
)
|
(0.07
)
|
(0.12
)
|
-
|
(0.01
)
|
|
Net realized gains
|
(2.94
)
|
(0.61
)
|
(1.47
)
|
(5.39
)
|
(2.67
)
|
|
Total distributions
|
(3.10
)
|
(0.68
)
|
(1.59
)
|
(5.39
)
|
(2.68
)
|
|
Net asset value, end of year
|
$42.60
|
$42.13
|
$34.65
|
$36.91
|
$53.63
|
|
Total return2
|
8.46
%
|
23.75
%
|
(2.06
)%
|
(23.28
)%
|
49.68
%
|
|
Net assets, end of year (millions)
|
$182
|
$200
|
$306
|
$381
|
$518
|
|
Ratios to average net assets:
|
|||||
|
Gross expenses
|
0.76
%
|
0.76
%
|
0.78
%
|
0.76
%
|
0.76
%
|
|
Net expenses3,4
|
0.75
|
0.75
|
0.75
|
0.75
|
0.75
|
|
Net investment income
|
0.37
|
0.39
|
0.38
|
0.22
|
0.17
|
|
Portfolio turnover rate
|
29
%
|
36
%
|
38
%
|
23
%
|
30
%
|
|
1
|
Per share amounts have been calculated using the average shares method.
|
|
2
|
Performance figures may reflect compensating balance arrangements, fee waivers and/or expense reimbursements.
In the absence of compensating balance arrangements, fee waivers and/or expense reimbursements, the total
return would have been lower. Past performance is no guarantee of future results.
|
|
3
|
As a result of an expense limitation arrangement, the ratio of total annual fund operating expenses, other than
interest, brokerage commissions, taxes, extraordinary expenses and acquired fund fees and expenses, to average
net assets of Class IS shares did not exceed 0.75%. In addition, the ratio of total annual fund operating expenses
for Class IS shares did not exceed the ratio of total annual fund operating expenses for Class I shares. These
expense limitation arrangements cannot be terminated prior to December 31, 2027 without the Board of Trustees'
consent. In addition, the manager has agreed to waive the Fund's management fee to an extent sufficient to offset
the net management fee payable in connection with any investment in an affiliated money market fund.
|
|
4
|
Reflects fee waivers and/or expense reimbursements.
|
|
ASSETS
|
||||
|
Description
|
Quoted Prices
(Level 1)
|
Other Significant
Observable Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
Total
|
|
Common Stocks†
|
$1,601,082,231
|
-
|
-
|
$1,601,082,231
|
|
Short-Term Investments†
|
29,556,871
|
-
|
-
|
29,556,871
|
|
Total Investments
|
$1,630,639,102
|
-
|
-
|
$1,630,639,102
|
|
†
|
See Schedule of Investments for additional detailed categorizations.
|
|
|
Total Distributable
Earnings (Loss)
|
Paid-in
Capital
|
|
(a)
|
$(15,689,001)
|
$15,689,001
|
|
Average Daily Net Assets
|
Annual Rate
|
|
First $1 billion
|
0.750
%
|
|
Next $1 billion
|
0.700
|
|
Next $3 billion
|
0.650
|
|
Next $5 billion
|
0.600
|
|
Over $10 billion
|
0.550
|
|
|
Class A
|
Class C
|
|
Sales charges
|
$134,165
|
-
|
|
CDSCs
|
2,601
|
$753
|
|
Purchases
|
$486,048,359
|
|
Sales
|
719,388,702
|
|
|
Cost
|
Gross
Unrealized
Appreciation
|
Gross
Unrealized
Depreciation
|
Net
Unrealized
Appreciation
|
|
Securities
|
$1,096,972,293
|
$575,592,283
|
$(41,925,474)
|
$533,666,809
|
|
|
Service and/or
Distribution Fees
|
Transfer Agent
Fees
|
|
Class 1
|
-
|
$2,165
|
|
Class A
|
$2,899,161
|
1,640,223
|
|
Class C
|
93,564
|
11,938
|
|
Class R
|
302,078
|
121,488
|
|
Class I
|
-
|
217,696
|
|
Class IS
|
-
|
5,376
|
|
Total
|
$3,294,803
|
$1,998,886
|
|
|
Waivers/Expense
Reimbursements
|
|
Class 1
|
$205
|
|
Class A
|
97,107
|
|
Class C
|
783
|
|
Class R
|
5,885
|
|
Class I
|
22,535
|
|
Class IS
|
21,454
|
|
Total
|
$147,969
|
|
|
Year Ended
October 31, 2025
|
Year Ended
October 31, 2024
|
|
Net Investment Income:
|
||
|
Class 1
|
$8,177
|
$4,484
|
|
Class A
|
501,607
|
-
|
|
Class C
|
-
|
-
|
|
Class R
|
-
|
-
|
|
Class I
|
756,677
|
356,984
|
|
Class IS
|
733,583
|
638,558
|
|
Total
|
$2,000,044
|
$1,000,026
|
|
|
Year Ended
October 31, 2025
|
Year Ended
October 31, 2024
|
|
Net Realized Gains:
|
||
|
Class 1
|
$200,256
|
$59,853
|
|
Class A
|
95,102,509
|
21,347,547
|
|
Class C
|
1,325,445
|
368,516
|
|
Class R
|
5,362,827
|
1,176,700
|
|
Class I
|
20,378,501
|
6,268,000
|
|
Class IS
|
13,590,805
|
5,294,419
|
|
Total
|
$135,960,343
|
$34,515,035
|
|
|
Year Ended
October 31, 2025
|
Year Ended
October 31, 2024
|
||
|
|
Shares
|
Amount
|
Shares
|
Amount
|
|
Class 1
|
||||
|
Shares sold
|
-
|
-
|
-
|
-
|
|
Shares issued on reinvestment
|
5,456
|
$208,433
|
1,844
|
$64,337
|
|
Shares repurchased
|
(18,511
)
|
(646,609
)
|
(28,091
)
|
(1,065,062
)
|
|
Net decrease
|
(13,055
)
|
$(438,176
)
|
(26,247
)
|
$(1,000,725
)
|
|
Class A
|
||||
|
Shares sold
|
2,264,948
|
$77,662,991
|
2,455,518
|
$82,361,898
|
|
Shares issued on reinvestment
|
2,649,803
|
93,644,024
|
643,655
|
20,915,104
|
|
Shares repurchased
|
(5,249,813
)
|
(181,129,021
)
|
(5,416,225
)
|
(183,507,675
)
|
|
Net decrease
|
(335,062
)
|
$(9,822,006
)
|
(2,317,052
)
|
$(80,230,673
)
|
|
Class C
|
||||
|
Shares sold
|
46,070
|
$1,042,705
|
50,906
|
$1,163,778
|
|
Shares issued on reinvestment
|
56,852
|
1,297,361
|
16,467
|
362,465
|
|
Shares repurchased
|
(219,130
)
|
(4,844,879
)
|
(257,789
)
|
(5,851,849
)
|
|
Net decrease
|
(116,208
)
|
$(2,504,813
)
|
(190,416
)
|
$(4,325,606
)
|
|
Class R
|
||||
|
Shares sold
|
130,852
|
$4,134,262
|
229,533
|
$7,330,813
|
|
Shares issued on reinvestment
|
159,992
|
5,338,938
|
37,951
|
1,172,441
|
|
Shares repurchased
|
(449,907
)
|
(14,414,933
)
|
(341,488
)
|
(11,021,958
)
|
|
Net decrease
|
(159,063
)
|
$(4,941,733
)
|
(74,004
)
|
$(2,518,704
)
|
|
|
Year Ended
October 31, 2025
|
Year Ended
October 31, 2024
|
||
|
|
Shares
|
Amount
|
Shares
|
Amount
|
|
Class I
|
||||
|
Shares sold
|
614,653
|
$25,388,027
|
1,450,833
|
$56,869,087
|
|
Shares issued on reinvestment
|
470,819
|
19,788,538
|
163,919
|
6,249,311
|
|
Shares repurchased
|
(2,403,584
)
|
(97,208,741
)
|
(5,030,576
)
|
(199,384,766
)
|
|
Net decrease
|
(1,318,112
)
|
$(52,032,176
)
|
(3,415,824
)
|
$(136,266,368
)
|
|
Class IS
|
||||
|
Shares sold
|
748,320
|
$31,033,136
|
1,629,521
|
$64,566,942
|
|
Shares issued on reinvestment
|
317,044
|
13,512,421
|
148,819
|
5,749,334
|
|
Shares repurchased
|
(1,553,994
)
|
(64,979,807
)
|
(5,858,274
)
|
(237,751,096
)
|
|
Net decrease
|
(488,630
)
|
$(20,434,250
)
|
(4,079,934
)
|
$(167,434,820
)
|
|
|
Affiliate
Value at
October 31,
2024
|
Purchased
|
Sold
|
||
|
Cost
|
Shares
|
Proceeds
|
Shares
|
||
|
Western Asset
Premier
Institutional U.S.
Treasury Reserves,
Premium Shares
|
$11,171,852
|
$138,661,521
|
138,661,521
|
$135,054,937
|
135,054,937
|
|
(cont'd)
|
Realized
Gain (Loss)
|
Dividend
Income
|
Net Increase
(Decrease) in
Unrealized
Appreciation
(Depreciation)
|
Affiliate
Value at
October 31,
2025
|
|
Western Asset Premier
Institutional U.S.
Treasury Reserves,
Premium Shares
|
-
|
$598,639
|
-
|
$14,778,436
|
|
|
2025
|
2024
|
|
Distributions paid from:
|
||
|
Ordinary income
|
$2,000,044
|
$1,000,026
|
|
Net long-term capital gains
|
135,960,343
|
34,515,035
|
|
Total distributions paid
|
$137,960,387
|
$35,515,061
|
|
Undistributed ordinary income - net
|
$29,471,407
|
|
Undistributed long-term capital gains - net
|
97,501,475
|
|
Total undistributed earnings
|
$126,972,882
|
|
Unrealized appreciation (depreciation)(a)
|
533,666,809
|
|
Total distributable earnings (loss) - net
|
$660,639,691
|
|
(a)
|
The difference between book-basis and tax-basis unrealized appreciation (depreciation) is attributable to the tax
deferral of losses on wash sales.
|
|
|
Pursuant to:
|
Amount Reported
|
|
Long-Term Capital Gain Dividends Distributed
|
§852(b)(3)(C)
|
$148,362,463
|
|
Income Eligible for Dividends Received Deduction (DRD)
|
§854(b)(1)(A)
|
$13,569,080
|
|
Qualified Dividend Income Earned (QDI)
|
§854(b)(1)(B)
|
$14,253,000
|
|
Qualified Net Interest Income (QII)
|
§871(k)(1)(C)
|
$783,271
|
|
Short-Term Capital Gain Dividends Distributed
|
§871(k)(2)(C)
|
$3,274,601
|
|
Qualified Business Income Dividends Earned
|
§199A
|
$2,754,515
|
|
Section 163(j) Interest Earned
|
§163(j)
|
$1,186,062
|
|
Interest Earned from Federal Obligations
|
Note (1)
|
$1,188,900
|
|
Changes in and Disagreements with Accountants
|
For the period covered by this report
|
|
Not applicable.
|
|
|
Results of Meeting(s) of Shareholders
|
For the period covered by this report
|
|
Not applicable.
|
|
|
Remuneration Paid to Directors, Officers and Others
|
For the period covered by this report
|
|
Refer to the financial statements included herein.
|
|
| ITEM 8. | CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS FOR OPEN-END MANAGEMENT INVESTMENT COMPANIES. |
The information is disclosed as part of the Financial Statements included in Item 7 of this Form N-CSR.
| ITEM 9. | PROXY DISCLOSURES FOR OPEN-END MANAGEMENT INVESTMENT COMPANIES. |
The information is disclosed as part of the Financial Statements included in Item 7 of this Form N-CSR.
| ITEM 10. | REMUNERATION PAID TO DIRECTORS, OFFICERS, AND OTHERS OF OPEN-END MANAGEMENT INVESTMENT COMPANIES. |
The information is disclosed as part of the Financial Statements included in Item 7 of this Form N-CSR.
| ITEM 11. | STATEMENT REGARDING BASIS FOR APPROVAL OF INVESTMENT ADVISORY CONTRACT. |
The information is disclosed as part of the Financial Statements included in Item 7 of this Form N-CSR, as applicable.
| ITEM 12. | DISCLOSURE OF PROXY VOTING POLICIES AND PROCEDURES FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES. |
Not applicable.
| ITEM 13. | PORTFOLIO MANAGERS OF CLOSED-END MANAGEMENT INVESTMENT COMPANIES. |
Not applicable.
| ITEM 14. | PURCHASES OF EQUITY SECURITIES BY CLOSED-END MANAGEMENT INVESTMENT COMPANY AND AFFILIATED PURCHASERS. |
Not applicable.
| ITEM 15. | SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS. |
There have been no changes to the procedures by which shareholders may recommend nominees to the Registrant's Board of Trustees that would require disclosure herein.
| ITEM 16. | CONTROLS AND PROCEDURES. |
| (a) | The Registrant's principal executive officer and principal financial officer have concluded that the Registrant's disclosure controls and procedures (as defined in Rule 30a- 3(c) under the Investment Company Act of 1940, as amended (the "1940 Act")) are effective as of a date within 90 days of the filing date of this report that includes the disclosure required by this paragraph, based on their evaluation of the disclosure controls and procedures required by Rule 30a-3(b) under the 1940 Act and 15d-15(b) under the Securities Exchange Act of 1934. |
| (b) | There were no changes in the Registrant's internal control over financial reporting (as defined in Rule 30a-3(d) under the 1940 Act) that occurred during the period covered by this report that have materially affected or are likely to materially affect the Registrant's internal control over financial reporting. |
| ITEM 17. | DISCLOSURE OF SECURITIES LENDING ACTIVITIES FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES. |
Not applicable.
| ITEM 18. | RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION. |
| (a) | Not applicable. |
| (b) | Not applicable. |
| ITEM 19. | EXHIBITS. |
Exhibit 99.CODE ETH
Exhibit 99.CERT
Exhibit 99.906CERT
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this Report to be signed on its behalf by the undersigned, there unto duly authorized.
Legg Mason Partners Investment Trust
| By: | /s/ Jane Trust | |
| Jane Trust | ||
| Chief Executive Officer |
| Date: | December 23, 2025 |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| By: | /s/ Jane Trust | |
| Jane Trust | ||
| Chief Executive Officer |
| Date: | December 23, 2025 |
| By: | /s/ Christopher Berarducci | |
| Christopher Berarducci | ||
| Principal Financial Officer |
| Date: | December 23, 2025 |